Satsuma Pharmaceuticals Inc

Available to platforms
R StocksTrader
Satsuma Pharmaceuticals Inc. (STSA) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for the acute treatment of migraine. Headquartered in South San Francisco, California, Satsuma leverages its proprietary Dry Powder Inhaler (DPI) technology to deliver fast-acting treatments, such as STS101, a nasal formulation of dihydroergotamine (DHE). The company focuses on addressing unmet medical needs in the migraine space by providing effective, patient-friendly solutions that offer rapid relief and improve quality of life. Satsuma is committed to advancing research and improving outcomes for those suffering from debilitating migraines.

Satsuma Pharmaceuticals Inc (STSA) on the NASDAQ Exchange

Company overview

Satsuma Pharmaceuticals Inc is a publicly listed company from USA with shares traded on NASDAQ under the ticker STSA. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for STSA are bid 1.07 USD and ask 1.11 USD.

Use the chart to review recent momentum, identify key price areas, and track how Satsuma Pharmaceuticals Inc is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add STSA to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.

Key facts

  • Exchange: NASDAQ
  • Company: Satsuma Pharmaceuticals Inc
  • Ticker: STSA
  • Country: USA
  • Bid1.07 USD
  • Ask1.11 USD
  • Quotes: real-time, auto-updated

Risk

Risk Warning: Past performance of STSA does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Satsuma Pharmaceuticals Inc (STSA) in R StocksTrader. Create and verify your profile, fund the account, search for STSA, and choose the instrument type available to you. Add STSA to your Watchlist to track moves and manage open positions throughout 2025.

STSA trades on NASDAQ and is issued by Satsuma Pharmaceuticals Inc. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for STSA match your plan.

Quotes update automatically in real time. Current levels for STSA are bid 1.07 USD and ask 1.11 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track STSA in R StocksTrader and adjust your approach as market conditions change in 2025.